Jasmeen Dara, MD, MS

Title(s)Associate Professor, Pediatrics
SchoolSchool of Medicine
Address550 16th. Street, #4585
San Francisco CA 94158
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tulane University School of Medicine, New Orleans, LAMD05/2007
    St. Christopher's Hospital for Children, Philadelphia, PA06/2010Pediatrics
    Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY06/2013Pediatric Infectious Diseases
    Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY06/2015Allergy & Immunology
    UCSF, San Francisco, CA10/2021Diversity, Equity, and Inclusion Champion Training

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia. Clin Immunol. 2024 Feb 15; 261:109942. Abraham RS, Basu A, Heimall JR, Dunn E, Yip A, Kapadia M, Kapoor N, Satter LF, Buckley R, O'Reilly R, Cuvelier GDE, Chandra S, Bednarski J, Chaudhury S, Moore TB, Haines H, Dávila Saldaña BJ, Chellapandian D, Rayes A, Chen K, Caywood E, Chandrakasan S, Lugt MTV, Ebens C, Teira P, Shereck E, Miller H, Aquino V, Eissa H, Yu LC, Gillio A, Madden L, Knutsen A, Shah AJ, DeSantes K, Barnum J, Broglie L, Joshi AY, Kleiner G, Dara J, Prockop S, Martinez C, Mousallem T, Oved J, Burroughs L, Marsh R, Torgerson TR, Leiding JW, Pai SY, Kohn DB, Pulsipher MA, Griffith LM, Notarangelo LD, Cowan MJ, Puck J, Dvorak CC, Haddad E. PMID: 38367737.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    2. Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection. Transplantation and Cellular Therapy. 2024 Feb 1; 30(2):s89. Grimley GM, Marón MG, Gomez GC, Prasad PV, Dara DJ, Lion LT, Papanicolaou PG, Fukushima FK, Wynn WR, Boeckh BM. .
      View in: Publisher Site   Mentions:
    3. Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc. Transplantation and Cellular Therapy. 2024 Feb 1; 30(2):s92-s93. Rayes RA, Logan LB, Liu LX, Dara DJ, Buckley BR, Oved OJ, Kapoor KN, Kapadia KM, Chandra CS, Martinez MC, Bunin BN, Chandrakasan CS, Burroughs BL, Bednarski BJ, Haines HH, Cuvelier CG, Eissa EH, Talano TJ, Saldana SB, Ebens EC, Chaudhury CS, Shereck SE, Aquino AV, Knutsen KA, Alexander AJ, Gillio GA, Chellapandian CD, Shah SA, Miller MH, Lugt LM, DeSantes DK, Dorsey DM, Parrott PR, O'Reilly OR, Aguayo-Hiraldo AP, Torgerson TT, Leiding LJ, Marsh MR, Griffith GL, Pulsipher PM, Kohn KD, Notarangelo NL, Cowan CM, Puck PJ, Heimall HJ, Haddad HE, Pai PS, Dvorak DC. .
      View in: Publisher Site   Mentions:
    4. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Blood. 2023 12 14; 142(24):2105-2118. Leiding JW, Arnold DE, Parikh S, Logan B, Marsh RA, Griffith LM, Wu R, Kidd S, Mallhi K, Chellapandian D, Si Lim SJ, Grunebaum E, Falcone EL, Murguia-Favela L, Grossman D, Prasad VK, Heimall JR, Touzot F, Burroughs LM, Bleesing J, Kapoor N, Dara J, Williams O, Kapadia M, Oshrine BR, Bednarski JJ, Rayes A, Chong H, Cuvelier GDE, Forbes Satter LR, Martinez C, Vander Lugt MT, Yu LC, Chandrakasan S, Joshi A, Prockop SE, Dávila Saldaña BJ, Aquino V, Broglie LA, Ebens CL, Madden LM, DeSantes K, Milner J, Rangarajan HG, Shah AJ, Gillio AP, Knutsen AP, Miller HK, Moore TB, Graham P, Bauchat A, Bunin NJ, Teira P, Petrovic A, Chandra S, Abdel-Azim H, Dorsey MJ, Birbrayer O, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Malech HL, Kang EM. PMID: 37562003; PMCID: PMC10862239.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection. Blood. 2023 Nov 28; 142(Supplement 1):112. Grimley GM, Maron MG, Gomez GC, Prasad PV, Dara DJ, Papanicolaou PG, Fukushima FK, Wynn WR, Boeckh BM. .
      View in: Publisher Site   Mentions:
    6. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study. J Allergy Clin Immunol. 2024 01; 153(1):275-286.e18. Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, von Bismarck P, Bloomfield M, Booth C, Buddingh EP, Cagdas D, Castelle M, Chan AY, Chandrakasan S, Chetty K, Cougoul P, Crickx E, Dara J, Deyà-Martínez A, Farmand S, Formankova R, Gennery AR, Gonzalez-Granado LI, Hagin D, Hanitsch LG, Hanzlikovà J, Hauck F, Ivorra-Cortés J, Kisand K, Kiykim A, Körholz J, Leahy TR, van Montfrans J, Nademi Z, Nelken B, Parikh S, Plado S, Ramakers J, Redlich A, Rieux-Laucat F, Rivière JG, Rodina Y, Júnior PR, Salou S, Schuetz C, Shcherbina A, Slatter MA, Touzot F, Unal E, Lankester AC, Burns S, Seppänen MRJ, Neth O, Albert MH, Ehl S, Neven B, Speckmann C. PMID: 37935260.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. J Allergy Clin Immunol. 2024 01; 153(1):287-296. Eissa H, Thakar MS, Shah AJ, Logan BR, Griffith LM, Dong H, Parrott RE, O'Reilly RJ, Dara J, Kapoor N, Forbes Satter L, Chandra S, Kapadia M, Chandrakasan S, Knutsen A, Jyonouchi SC, Molinari L, Rayes A, Ebens CL, Teira P, Dávila Saldaña BJ, Burroughs LM, Chaudhury S, Chellapandian D, Gillio AP, Goldman F, Malech HL, DeSantes K, Cuvelier GDE, Rozmus J, Quinones R, Yu LC, Broglie L, Aquino V, Shereck E, Moore TB, Vander Lugt MT, Mousallem TI, Oved JH, Dorsey M, Abdel-Azim H, Martinez C, Bleesing JH, Prockop S, Kohn DB, Bednarski JJ, Leiding J, Marsh RA, Torgerson T, Notarangelo LD, Pai SY, Pulsipher MA, Puck JM, Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Heimall J. PMID: 37793572.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet. 2023 07 08; 402(10396):129-140. Thakar MS, Logan BR, Puck JM, Dunn EA, Buckley RH, Cowan MJ, O'Reilly RJ, Kapoor N, Satter LF, Pai SY, Heimall J, Chandra S, Ebens CL, Chellapandian D, Williams O, Burroughs LM, Saldana BD, Rayes A, Madden LM, Chandrakasan S, Bednarski JJ, DeSantes KB, Cuvelier GDE, Teira P, Gillio AP, Eissa H, Knutsen AP, Goldman FD, Aquino VM, Shereck EB, Moore TB, Caywood EH, Lugt MTV, Rozmus J, Broglie L, Yu LC, Shah AJ, Andolina JR, Liu X, Parrott RE, Dara J, Prockop S, Martinez CA, Kapadia M, Jyonouchi SC, Sullivan KE, Bleesing JJ, Chaudhury S, Petrovic A, Keller MD, Quigg TC, Parikh S, Shenoy S, Seroogy C, Rubin T, Decaluwe H, Routes JM, Torgerson TR, Leiding JW, Pulsipher MA, Kohn DB, Griffith LM, Haddad E, Dvorak CC, Notarangelo LD. PMID: 37352885; PMCID: PMC10386791.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    9. 345 Prophylactic Tocilizumab Decreases Incidence of Acute Graft-Versus-Host Disease Following Alpha/Beta T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Children and Young Adults. Transplantation and Cellular Therapy. 2023 Feb 1; 29(2):s263-s264. Cho CS, Dvorak DC, Higham HC, Cisneros CG, Chu CJ, Melton MA, Winestone WL, Shimano SK, Dara DJ, Hermiston HM, Huang HJ, Long-Boyle LJ, Kharbanda KS. .
      View in: Publisher Site   Mentions:
    10. 172 Diagnosing and Grading of SOS: Which Criteria Are Best?. Transplantation and Cellular Therapy. 2023 Feb 1; 29(2):s138-s139. Cisneros CG, Dvorak DC, Kharbanda KS, Shimano SK, Melton MA, Chu CJ, Winestone WL, Dara DJ, Huang HJ, Hermiston HM, Higham HC. .
      View in: Publisher Site   Mentions:
    11. Lentiviral Gene Therapy for Artemis-Deficient SCID. N Engl J Med. 2022 12 22; 387(25):2344-2355. Cowan MJ, Yu J, Facchino J, Fraser-Browne C, Sanford U, Kawahara M, Dara J, Long-Boyle J, Oh J, Chan W, Chag S, Broderick L, Chellapandian D, Decaluwe H, Golski C, Hu D, Kuo CY, Miller HK, Petrovic A, Currier R, Hilton JF, Punwani D, Dvorak CC, Malech HL, McIvor RS, Puck JM. PMID: 36546626; PMCID: PMC9884487.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    12. Impact of Genetic Diagnosis on the Outcome of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Disorders. J Clin Immunol. 2023 04; 43(3):636-646. Forlanini F, Chan A, Dara J, Dvorak CC, Cowan MJ, Puck JM, Dorsey MJ. PMID: 36495401; PMCID: PMC9958161.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    13. Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients. J Clin Immunol. 2022 Oct; 42(7):1580-1581. Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein DD, Hsu AP, Holland SM, Krance R, Sasa G, Kumar AR, Müller I, de Sousa MA, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese MP, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks JP, Dokmeci E, Dara J, Lucas CL, Hambleton S, Wilson K, Jolles S, Koc Y, Güngör T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry JA, Meyts I. PMID: 35499644; PMCID: PMC9674743.
      View in: PubMed   Mentions: 1     Fields:    
    14. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients. Pediatr Blood Cancer. 2022 05; 69(5):e29641. Higham CS, Shimano KA, Melton A, Kharbanda S, Chu J, Dara J, Winestone LE, Hermiston ML, Huang JN, Dvorak CC. PMID: 35253361.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    15. 125 Hematopoietic Cell Transplantation in 240 Patients with Chronic Granulomatous Disease: A Pidtc Report. Transplantation and Cellular Therapy. 2022 Mar 1; 28(3):s101-s103. Arnold AD, Parikh PS, Logan LB, Marsh MR, Griffith GL, Wu WR, Mallhi MK, Chellapandian CD, Si SS, Grunebaum GE, Broglie BL, Prasad PV, Heimall HJ, Bunin BN, Teira TP, Touzot TF, Burroughs BL, Petrovic PA, Bleesing BJ, Chandra CS, Kapoor KN, Dara DJ, Dorsey DM, Williams WO, Kapadia KM, Bednarski BJ, Rayes RA, Chen CK, Chong CH, Cuvelier CG, Forbes FL, Martinez MC, Lugt LM, Yu YL, Chandrakasan CS, Joshi JA, Prockop PS, Saldana SB, Aquino AV, Ebens EC, Madden ML, DeSantes DK, Milner MJ, Rangarajan RH, Shah SA, Gillio GA, Knutsen KA, Miller MH, Moore MT, Wright WN, Cowan CM, Dvorak DC, Haddad HE, Kohn KD, Notarangelo NL, Pai PS, Puck PJ, Pulsipher PM, Torgerson TT, Malech MH, Kang KE, Leiding LJ. .
      View in: Publisher Site   Mentions:
    16. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients. J Clin Immunol. 2021 10; 41(7):1633-1647. Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, Taskinen M, Koskenvuo M, Saarela J, Dimitrova D, Hickstein DD, Hsu AP, Holland SM, Krance R, Sasa G, Kumar AR, Müller I, de Sousa MA, Delafontaine S, Moens L, Babor F, Barzaghi F, Cicalese MP, Bredius R, van Montfrans J, Baretta V, Cesaro S, Stepensky P, Benedicte N, Moshous D, Le Guenno G, Boutboul D, Dalal J, Brooks JP, Dokmeci E, Dara J, Lucas CL, Hambleton S, Wilson K, Jolles S, Koc Y, Güngör T, Schnider C, Candotti F, Steinmann S, Schulz A, Chambers C, Hershfield M, Ombrello A, Kanakry JA, Meyts I. PMID: 34324127; PMCID: PMC8452581.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    17. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J Allergy Clin Immunol. 2022 01; 149(1):410-421.e7. Dimitrova D, Nademi Z, Maccari ME, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, Rao K, Worth AJJ, Laberko A, Mukhina A, Néven B, Moshous D, Speckmann C, Warnatz K, Wehr C, Abolhassani H, Aghamohammadi A, Bleesing JJ, Dara J, Dvorak CC, Ghosh S, Kang HJ, Markelj G, Modi A, Bayer DK, Notarangelo LD, Schulz A, Garcia-Prat M, Soler-Palacín P, Karakükcü M, Yilmaz E, Gambineri E, Menconi M, Masmas TN, Holm M, Bonfim C, Prando C, Hughes S, Jolles S, Morris EC, Kapoor N, Koltan S, Paneesha S, Steward C, Wynn R, Duffner U, Gennery AR, Lankester AC, Slatter M, Kanakry JA. PMID: 34033842; PMCID: PMC8611111.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    18. Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Blood Adv. 2021 04 27; 5(8):2106-2114. Higham CS, Collins G, Shimano KA, Melton A, Kharbanda S, Winestone LE, Huang JN, Dara J, Long-Boyle JR, Dvorak CC. PMID: 33877298; PMCID: PMC8095147.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). J Clin Immunol. 2021 04; 41(3):680-683. Brooks JP, Rice AJ, Ji W, Lanahan SM, Konstantino M, Dara J, Hershfield MS, Cruickshank A, Dokmeci E, Lakhani S, Lucas CL. PMID: 33394316.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. 2 Immunologic recovery and basis for infections in the pediatric hematopoietic stem cell transplant recipient. . 2021 Jan 1; 10-21.e3. Dara DJ, Dvorak DC. .
      View in: Publisher Site   Mentions:
    21. Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients. Transpl Infect Dis. 2021 Apr; 23(2):e13504. Forlanini F, Dara J, Dvorak CC, Cowan MJ, Puck JM, Dorsey MJ. PMID: 33169931; PMCID: PMC8287897.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    22. A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients. Blood. 2020 Nov 5; 136(Supplement 1):9-10. Higham HC, Melton MA, Kharbanda KS, Dara DJ, Winestone WL, Huang HJ, Shimano SK. .
      View in: Publisher Site   Mentions:
    23. Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants. Biol Blood Marrow Transplant. 2020 09; 26(9):1646-1654. Contreras CF, Long-Boyle JR, Shimano KA, Melton A, Kharbanda S, Dara J, Higham C, Huang JN, Cowan MJ, Dvorak CC. PMID: 32534101.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. International Retrospective Study of Allogeneic Hematopoietic Cell Transplantation (HCT) for Activated Phosphoinositide 3-Kinase Delta (PI3K) Syndrome. Biology of Blood and Marrow Transplantation. 2020 Mar 1; 26(3):s14-s15. Dimitrova DD, Nademi NZ, Maccari MM, Ehl ES, Lankester LA, Gennery GA, Uzel UG, Laberko LA, Mukhina MA, Ip IW, Rao RK, Worth WA, Speckmann SC, Wehr WC, Abolhassani AH, Aghamohammadi AA, Bleesing BJ, Dara DJ, Dvorak DC, Ghosh GS, Kang KH, Markelj MG, Modi MA, Bayer BD, Notarangelo NL, Schulz SA, Garcia-Prat GM, Soler-Palacin SP, Kurakukcu KM, Yilmaz YE, Slatter SM, Kanakry KJ. .
      View in: Publisher Site   Mentions:
    25. Early Outcome of a Phase I/II Clinical Trial (NCT03538899) of Gene-Corrected Autologous CD34+ Hematopoietic Cells and Low-Exposure Busulfan in Newly Diagnosed Patients with Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID). Biology of Blood and Marrow Transplantation. 2020 Mar 1; 26(3):s88-s89. Cowan CM, Yu YJ, Facchino FJ, Chag CS, Fraser-Browne FC, Long-Boyle LJ, Kawahara KM, Sanford SU, Oh OJ, Teoh TS, Punwani PD, Dara DJ, Dvorak DC, Broderick BL, Hu HD, Miller MH, Petrovic PA, Malech MH, McIvor MR, Puck PJ. .
      View in: Publisher Site   Mentions:
    26. Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants. Blood. 2019 Nov 13; 134(Supplement_1):4481-4481. Contreras CC, Long-Boyle LJ, Shimano SK, Dara DJ, Huang HJ, Kharbanda KS, Melton MA, Higham HC, Cowan CM, Dvorak DC. .
      View in: Publisher Site   Mentions:
    27. Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis. Blood. 2019 Nov 13; 134(Supplement_1):3343-3343. Dain DA, Hermiston HM, Shimano SK, Kharbanda KS, Melton MA, Dara DJ, Huang HJ, Dvorak DC. .
      View in: Publisher Site   Mentions:
    28. Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency. Biol Blood Marrow Transplant. 2019 07; 25(7):1355-1362. Dvorak CC, Long-Boyle J, Dara J, Melton A, Shimano KA, Huang JN, Puck JM, Dorsey MJ, Facchino J, Chang CK, Cowan MJ. PMID: 30876930; PMCID: PMC7384257.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    29. The Impact of Total Body Irradiation-Based Regimens on Outcomes in Children and Young Adults with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019 Mar 1; 25(3):s197-s198. Friend FB, Bailey-Olson BM, Higham HC, Dara DJ, Melton MA, Shimano SK, Huang HJ, Kharbanda KS, Dvorak DC. .
      View in: Publisher Site   Mentions:
    30. Low Birth Weight in Human Immunodeficiency Virus-Exposed Uninfected Infants in Bronx, New York. J Pediatric Infect Dis Soc. 2018 May 15; 7(2):e24-e29. Dara JS, Hanna DB, Anastos K, Wright R, Herold BC. PMID: 29301007; PMCID: PMC5954301.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    31. Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report. Drug Saf Case Rep. 2018 May 11; 5(1):22. Farhat L, Dara J, Duberstein S, De A. PMID: 29752554; PMCID: PMC5948191.
      View in: PubMed   Mentions: 2  
    32. Optimal Antiretroviral Prophylaxis in Infants at High Risk of Acquiring HIV: A Systematic Review. Pediatr Infect Dis J. 2018 02; 37(2):169-175. Beste S, Essajee S, Siberry G, Hannaford A, Dara J, Sugandhi N, Penazzato M. PMID: 29319636.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    33. Fulminant Sepsis Due to Granulibacter bethesdensis in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease. Pediatr Infect Dis J. 2017 Dec; 36(12):1165-1166. Mayer EF, Gialanella P, Munjal I, Cunningham-Rundles C, Dara J. PMID: 28650935; PMCID: PMC5897898.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    34. Consanguineous Siblings with a Novel Mutation in Lipopolysaccharide-Responsive Beige-like Anchor protein (LRBA). Journal of Allergy and Clinical Immunology. 2017 Feb 1; 139(2):ab16. Mehta MR, Thompson TJ, Fradin FK, Dara DJ. .
      View in: Publisher Site   Mentions:
    35. Multivariable analysis to determine if HIV-1 Tat dicysteine motif is associated with neurodevelopmental delay in HIV-infected children in Malawi. Behav Brain Funct. 2015 Dec 17; 11:38. Dara J, Dow A, Cromwell E, Sturdevant CB, Mallewa M, Swanstrom R, Van Rie A, Prasad VR. PMID: 26678821; PMCID: PMC4683967.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    36. Adherence to Therapy in Chronic Granulomatous Disease and Disease Outcomes: A Possibility for Development of New Therapeutic Delivery Devices. Journal of Allergy and Clinical Immunology. 2015 Feb 1; 135(2):ab103. Dara DJ, Falcon FJ, Shliozberg SJ, Conway CD. .
      View in: Publisher Site   Mentions:
    37. Clinical and Virological Characteristics Of HIV-Associated Lymphomas In Patients With Perinatally-Acquired HIV In The Era Of Antiretroviral Therapy. Journal of Allergy and Clinical Immunology. 2014 Feb 1; 133(2):ab97. Dara DJ, Barta BS, Shliozberg SJ. .
      View in: Publisher Site   Mentions:
    38. Microbiological and Genetic Characterization of Carbapenem-Resistant Klebsiella pneumoniae Isolated From Pediatric Patients. J Pediatric Infect Dis Soc. 2014 Mar; 3(1):e10-4. Dara JS, Chen L, Levi MH, Kreiswirth BN, Pellett Madan R. PMID: 24567846; PMCID: PMC3933046.
      View in: PubMed   Mentions: 7     Fields:    
    39. Resident comfort level after receiving child abuse training: a survey of pediatric chief residents. Child Abuse Negl. 2013 Jul; 37(7):489-91. Dara JS, Kotlar EY, Leekoff ML, Tran XG, McColgan MD, Giardino AP. PMID: 23294604.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    40. Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred. J Allergy Clin Immunol. 2010 Jul; 126(1):172-5. Conway DH, Dara J, Bagashev A, Sullivan KE. PMID: 20538326.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    41. Pseudomonas Susceptibility in a Large MyD88 Deficient Kindred And The Use of IVIG Replacement Therapy. Journal of Allergy and Clinical Immunology. 2010 Feb 1; 125(2):ab11. Poliak PN, Jyonouchi JS, Forbes FL, Dara DJ, Conway CD, Sullivan SK. .
      View in: Publisher Site   Mentions: